A detailed history of Bridgecreek Investment Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bridgecreek Investment Management, LLC holds 40,335 shares of MRK stock, worth $4 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
40,335
Previous 47,935 15.85%
Holding current value
$4 Million
Previous $4.93 Million 10.88%
% of portfolio
0.85%
Previous 1.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $761,368 - $828,552
-7,600 Reduced 15.85%
40,335 $4.4 Million
Q3 2023

Oct 27, 2023

SELL
$102.95 - $114.33 $109,127 - $121,189
-1,060 Reduced 2.16%
47,935 $4.93 Million
Q2 2023

Aug 03, 2023

SELL
$108.61 - $118.38 $40,728 - $44,392
-375 Reduced 0.76%
48,995 $5.65 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $113,234 - $126,346
-1,100 Reduced 2.18%
49,370 $5.25 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $546,500 - $700,687
-6,250 Reduced 11.02%
50,470 $5.6 Million
Q3 2022

Nov 07, 2022

SELL
$84.53 - $94.96 $46,491 - $52,228
-550 Reduced 0.96%
56,720 $4.89 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $1.1 Million - $1.25 Million
13,205 Added 29.97%
57,270 $5.22 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $3 Million - $3.36 Million
40,790 Added 1245.5%
44,065 $3.62 Million
Q4 2021

Jan 27, 2022

SELL
$72.28 - $90.54 $41,561 - $52,060
-575 Reduced 14.94%
3,275 $251,000
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $21,633 - $25,440
-375 Reduced 8.88%
3,850 $273,000
Q2 2018

Aug 03, 2018

SELL
$50.83 - $59.72 $1,270 - $1,493
-25 Reduced 0.59%
4,225 $256,000
Q1 2018

Apr 25, 2018

BUY
$50.96 - $59.23 $19,110 - $22,211
375 Added 9.68%
4,250 $231,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,875
3,875 $248,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bridgecreek Investment Management, LLC Portfolio

Follow Bridgecreek Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgecreek Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgecreek Investment Management, LLC with notifications on news.